Gordon David N.
Insider CIK 1751167 · ACRS Chief Medical Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-07-13 | 2021-07-14 | 2,631 | $16.98 | $44.7K | 147,447 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-07-02 | 2021-07-07 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-07-02 | 2021-07-07 | 6,000 | — | $0 | 150,078 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 31,114 | $21.50 | $669.0K | 150,878 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-02 | 2021-06-02 | 6,800 | $22.26 | $151.4K | 144,078 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-06-01 | 2021-06-02 | 87,500 | — | $0 | 0 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 4,885 | $23.57 | $115.1K | 181,992 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | S Sale | 2021-06-01 | 2021-06-02 | 9,115 | $22.71 | $207.0K | 186,877 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-06-01 | 2021-06-02 | 87,500 | — | $0 | 195,992 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-03-02 | 2021-03-03 | 8,297 | — | $0 | 24,892 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-03-02 | 2021-03-03 | 8,297 | — | $0 | 110,772 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-03-02 | 2021-03-03 | 2,280 | $23.25 | $53.0K | 108,492 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 28,400 | — | $0 | 28,400 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2021-03-01 | 2021-03-03 | 99,500 | — | $0 | 99,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2021-03-01 | 2021-03-03 | 20,600 | — | $0 | 41,200 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2021-03-01 | 2021-03-03 | 5,660 | $24.06 | $136.2K | 102,475 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2021-03-01 | 2021-03-03 | 20,600 | — | $0 | 108,135 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-07-02 | 2020-07-07 | 6,000 | — | $0 | 12,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-07-02 | 2020-07-07 | 1,360 | $1.50 | $2.0K | 87,535 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-07-02 | 2020-07-07 | 6,000 | — | $0 | 88,895 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-06-01 | 2020-06-03 | 87,500 | — | $0 | 87,500 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-06-01 | 2020-06-03 | 87,500 | — | $0 | 106,940 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-06-01 | 2020-06-03 | 24,045 | $1.32 | $31.7K | 82,895 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 33,189 | — | $0 | 33,189 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2020-03-02 | 2020-03-04 | 20,600 | — | $0 | 61,800 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2020-03-02 | 2020-03-04 | 116,160 | — | $0 | 116,160 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2020-03-02 | 2020-03-04 | 20,600 | — | $0 | 24,952 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2020-03-02 | 2020-03-04 | 5,512 | $1.26 | $6.9K | 19,440 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-10-30 | 2019-10-31 | 175,000 | — | $0 | 175,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise deriv | 2019-07-02 | 2019-07-03 | 6,000 | — | $0 | 18,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | M Exercise | 2019-07-02 | 2019-07-03 | 6,000 | — | $0 | 6,000 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | F Tax w/h | 2019-07-02 | 2019-07-03 | 1,648 | $2.34 | $3.9K | 4,352 | SEC↗ |
| ACRS Aclaris Therapeutics, Inc. | A Award deriv | 2019-03-01 | 2019-03-04 | 82,400 | — | $0 | 82,400 | SEC↗ |